Sign In
Buy MYOV
$26.98
+0 (+0%)
At Close: Jun 08, 2023
Myovant Sciences inks deal for relugolix combination outside U.S.
11:25am, Tuesday, 31'st Mar 2020
Myovant Sciences (NYSE:MYOV) has entered into an exclusive license agreement with Gedeon Richter Plc., a Central Eastern Europe-based pharmaceutical company, where the latter will commercialize rel
Myovant Sciences, Gedeon Richter enter license agreement for relugolix MYOV
10:38am, Tuesday, 31'st Mar 2020
Myovant Sciences, Gedeon Richter enter license agreement for relugolix MYOV
Stocks gain to end worst month since 2008 crisis, FX firmer
10:07am, Tuesday, 31'st Mar 2020
PRAGUE — Central European stock marketsregained some ground on Tuesday after Chinese data offering somerelief for global investors, but remained on course for theirbiggest monthly drop since …
CEE MARKETS-Stocks gain to end worst month since 2008 crisis, FX firmer
10:05am, Tuesday, 31'st Mar 2020
Central European stock markets regained some ground on Tuesday after Chinese data offering some relief for global investors, but remained on course for their biggest monthly drop since the 2008 financ
Insider Buying: Myovant Sciences Ltd (NYSE:MYOV) Major Shareholder Purchases 140,000 Shares of Stock
09:00am, Tuesday, 31'st Mar 2020
Myovant Sciences Ltd (NYSE:MYOV) major shareholder Chemical Co. Ltd. Sumitomo purchased 140,000 shares of the company’s stock in a transaction on Friday, March 27th. The stock was bought at an avera
BRIEF-Hungary's Richter enters deal with Myovant Sciences on uterine fibroid medicine
06:12am, Tuesday, 31'st Mar 2020
Richter Gedeon Vegyeszeti Gyar Nyrt :
BRIEF-Myovant Sciences And Gedeon Richter Enter Exclusive License Agreement To Commercialize Relugolix Combination Tablet
06:05am, Tuesday, 31'st Mar 2020
Myovant Sciences Ltd:
Myovant Sciences (MYOV), a healthcare company focused on developing innovative treatments for women's health and prostate cancer, and Gedeon Richter Plc., a major pharmaceutical company in Central Eas
The Week Ahead In Biotech: Clinical Readouts, COVID-19 News Flow In Focus Amid Continuing Uncertainty
04:10pm, Sunday, 29'th Mar 2020
After starting the week ended March 28 on the backfoot, biotech stocks recovered through the week. Activity in the space remained light, although coronavirus (COVID-19) news flow continued to dominate
Daily Insider Ratings Round Up 3/26/20
06:32am, Sunday, 29'th Mar 2020
Tables of the top insider purchases and sales filed with the SEC on 3/26/20, based on dollar value. Dollar values often do not equate with significance when it
Myovant Sciences Ltd (NYSE:MYOV) Major Shareholder Chemical Co. Ltd. Sumitomo Buys 108,100 Shares
08:24am, Saturday, 28'th Mar 2020
Myovant Sciences Ltd (NYSE:MYOV) major shareholder Chemical Co. Ltd. Sumitomo purchased 108,100 shares of the company’s stock in a transaction dated Wednesday, March 25th. The shares were acquired a
Myovant Sciences (NYSE:MYOV) Upgraded to "Strong-Buy" at ValuEngine
06:30am, Saturday, 28'th Mar 2020
ValuEngine upgraded shares of Myovant Sciences (NYSE:MYOV) from a buy rating to a strong-buy rating in a research note released on Tuesday, ValuEngine reports. MYOV has been the topic of several other
Myovant Sciences (NYSE:MYOV) Trading Up 7.4% After Insider Buying Activity
05:38am, Friday, 27'th Mar 2020
Shares of Myovant Sciences Ltd (NYSE:MYOV) were up 7.4% during mid-day trading on Thursday following insider buying activity. The stock traded as high as $8.35 and last traded at $8.11, approximately
Daily Insider Ratings Round-Up 3/24/20
04:42pm, Thursday, 26'th Mar 2020
Tables of the top insider purchases and sales filed with the SEC on 3/24/20, based on dollar value. Dollar values often do not equate with significance when it
Insider Buying: Myovant Sciences Ltd (NYSE:MYOV) Major Shareholder Acquires 405,100 Shares of Stock
10:00am, Wednesday, 25'th Mar 2020
Myovant Sciences Ltd (NYSE:MYOV) major shareholder Chemical Co. Ltd. Sumitomo purchased 405,100 shares of the firm’s stock in a transaction dated Monday, March 23rd. The shares were purchased at an
